Stephen J. Hoffman - Jul 15, 2022 Form 4 Insider Report for ACELRX PHARMACEUTICALS INC (ACRX)

Role: Director
Signature: /s/ Martha Adler, Attorney-In-Fact
Stock symbol: ACRX
Transactions as of: Jul 15, 2022
Transactions value $: $0
Form type: 4
Date filed: 7/15/2022, 07:29 PM
Previous filing: Dec 29, 2021
Next filing: Dec 13, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ACRX	Common Stock	Award	$0	+15.5K	+72.94%	$0.00	36.8K	Jul 15, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ACRX	Stock Option (Right to Buy)	Award	$0	+31K		$0.00	31K	Jul 15, 2022	Common Stock	31K	$0.23	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2	100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.
F3	100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.